Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,462 | 3,442 | 3,823 | -1,134 | 613 |
| Depreciation Amortization | 6,313 | 3,133 | 12,615 | 9,356 | 5,864 |
| Income taxes - deferred | N/A | -304 | -8,210 | N/A | -443 |
| Accounts receivable | 4,574 | -787 | -22,031 | -12,827 | -3,891 |
| Accounts payable and accrued liabilities | -6,473 | -3,302 | 11,311 | 9,201 | -484 |
| Other Working Capital | -12,906 | -9,519 | 618 | 3,119 | 4,132 |
| Other Operating Activity | 5,704 | 6,402 | 21,266 | 9,323 | 8,291 |
| Operating Cash Flow | $4,674 | $-935 | $19,392 | $17,038 | $14,082 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,514 | -687 | -2,246 | -3,799 | -2,297 |
| Net Acquisitions | -18,600 | -18,600 | -55,123 | -57,632 | -57,931 |
| Purchase Sale Intangibles | -768 | -669 | -5,094 | N/A | N/A |
| Other Investing Activity | -768 | -669 | -5,094 | 0 | 0 |
| Investing Cash Flow | $-20,882 | $-19,956 | $-62,463 | $-61,431 | $-60,228 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 22,000 | 11,300 | 7,300 | 6,000 |
| Debt Issued | 55,300 | N/A | 25,000 | 25,000 | 25,000 |
| Debt Repayment | -37,586 | -2,142 | -4,359 | -2,230 | -93 |
| Common Stock Issued | 3,847 | 2,115 | 1,857 | 970 | 770 |
| Other Financing Activity | 403 | 81 | -381 | 125 | -612 |
| Financing Cash Flow | $21,964 | $22,054 | $33,417 | $31,165 | $31,065 |
| Exchange Rate Effect | 97 | 134 | -105 | -88 | -778 |
| Beginning Cash Position | 23,057 | 23,057 | 32,816 | 32,816 | 32,816 |
| End Cash Position | 28,910 | 24,354 | 23,057 | 19,500 | 16,957 |
| Net Cash Flow | $5,853 | $1,297 | $-9,759 | $-13,316 | $-15,859 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,674 | -935 | 19,392 | 17,038 | 14,082 |
| Capital Expenditure | -1,514 | -687 | -2,246 | -3,799 | -2,297 |
| Free Cash Flow | 3,160 | -1,622 | 17,146 | 13,239 | 11,785 |